Dear Editor: Your recent article, “CME's Voice in Washington,” [March/April 2006] and the call to form a government advocacy task force is a critical and time-sensitive rescue mission that should be carried out by professionals in the CME industry and other collaborators. The future of CME will be contingent upon whether we can develop business models with less dependency on pharmaceutical support and more emphasis on outcomes and how CME impacts and adds value to the marketplace. I believe ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Letters to the Editor, you'll get exclusive access to a large archive of premium content.

Already registered? here.